Avalyn 药
AVLN
23.66
-0.98
-3.98%
Avalyn 药
US · AVLN
#3161 按市值排名
上市于 2026
23.66
-0.98
-3.98%
实时 - 追踪5344个代码 - 心跳于403秒前
· 2026-10-16 19:30
最新新闻
-
Jefferies Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Maintains Target Price $52\u5e02\u573a\u8d44\u8baf · 2026/8/13
-
评级变动
Morgan Stanley Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $53\u5e02\u573a\u8d44\u8baf · 2026/6/4
-
Morgan Stanley Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Raises Target Price to $57\u5e02\u573a\u8d44\u8baf · 2026/8/13
-
Analysts Offer Insights on NA Companies: Avalyn Pharma Inc (AVLN) and EquipmentShare.com, Inc. (EQPT)TipRanks · 2026/8/13
-
评级变动
Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN)TipRanks · 2026/6/4
-
Raymond James Initiates Avalyn Pharma(AVLN.US) With Buy Rating, Announces Target Price $60\u5e02\u573a\u8d44\u8baf · 2026/10/2
-
评级变动
Evercore Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $51\u5e02\u573a\u8d44\u8baf · 2026/5/26
-
评级变动
Jefferies Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $52\u5e02\u573a\u8d44\u8baf · 2026/5/25
-
Jefferies Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $52\u5e02\u573a\u8d44\u8baf · 2026/5/26
-
评级变动
Morgan Stanley Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $53\u5e02\u573a\u8d44\u8baf · 2026/5/26
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
Avalyn 药 讨论区 0 条评论